This week, 10 stocks get F’s (“strong sell”) in ‘s three main grading categories, Total Grade, Overall Fundamental Grade and Quantitative Grade.
These are the worst of the worst in the entire Portfolio Grader database. This week, there are 4,325 stocks and only these 10 get failing marks in all categories to make the dreaded “Triple F” stocks list. Here they are:
Aeropostale, Inc. () is a mall-based specialty retailer of casual apparel and accessories. The price of ARO is down 16.5% since the first of the year. This is worse than the S&P 500, which has remained flat over the same period. As of Feb. 14, 2014, 28.8% of outstanding Aeropostale, Inc. shares were held short. .
Advantest Corp. Sponsored ADR () manufactures and sells semiconductor and component test system products, and mechatronics-related products. Shares of ATE stock have fallen 13.1% since January 1. .
Allegheny Technologies Incorporated () produces specialty metals such as titanium alloys and superalloys. The price of ATI has slipped 5.1% since the start of the year. .
Gafisa S.A. Sponsored ADR () acquires, operates, and develops real estate. Shares of GFA have seen a 21.2% drop since January 1. .
Harmony Gold Mining Co. Ltd. Sponsored ADR () is a mining company that produces gold from its operations in the district of Virginia, Orange Free State. .
Hatteras Financial () is a mortgage real estate investment trust. .
Intrepid Potash, Inc. () mines and markets potash for use as a fertilizer. Since the start of the year, IPI has declined 6.4%. As of Feb. 14, 2014, 13.1% of outstanding Intrepid Potash, Inc. shares were held short. The stock has a trailing PE Ratio of 46.50. .
McDermott International, Inc. () is a worldwide energy services company. As of Feb. 14, 2014, 15.1% of outstanding McDermott International, Inc. shares were held short. .
American Capital Mortgage Investment Corp. () invests in, finances, and manages a portfolio of mortgage-related investments, such as agency mortgage investments, non-agency mortgage investments and other mortgage-related investments. .
Spectrum Pharmaceuticals, Inc. () is a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology. As of Feb. 14, 2014, 21.6% of outstanding Spectrum Pharmaceuticals, Inc. shares were held short. .
91抖阴’s proprietary stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool .
